AST2818

Alflutinib is a potent inhibitor of EGFR. Alflutinib inhibits EGFR active mutations as well as the T790M acquired resistant mutation. Alflutinib has the potential for the research of cancer diseases, especially non-small cell lung cancer (NSCLC).


Cat. No.: EX-A2868-1	Purity: >98%

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
100mg	750	In-stock
200mg	1100	In-stock
500mg	1700	In-stock
1g	2600	In-stock
5g	7750	In-stock
10g	12800	In-stock

Send PO to E-mail:order@excenen.com; or Fax:+86 020 81619670

Discount Request


Synonyms	Alflutinib
Synonyms 2	Furmonertinib
CAS No.	1869057-83-9
Purity	>98%
Formula	C28H31F3N8O2
Mol Weight	568.5933

Reference:	[1]. Y. Shi, et al. P2.03-028 Third Generation EGFR Inhibitor AST2818 (Alflutinib) in NSCLC Patients with EGFR T790M Mutation: A phase1/2 Multi-Center Clinical Trial.
CoA	CoA of AST2818

Smiles:	CN(C)CCN(C)C1=NC(OCC(F)(F)F)=C(NC2=NC=CC(=N2)C2=CN(C)C3=C2C=CC=C3)C=C1NC(=O)C=C


		Search